---
title: "石药集团宣布，罗哌卡因长效注射剂已获准在中国开展临床试验"
description: "石药集团表示，罗哌卡因长效注射剂已获得中国临床试验批准"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/276051793.md"
published_at: "2026-02-16T10:56:34.000Z"
---

# 石药集团宣布，罗哌卡因长效注射剂已获准在中国开展临床试验

> 石药集团表示，罗哌卡因长效注射剂已获得中国临床试验批准

### Related Stocks

- [516500.CN - 华夏中证生物科技主题ETF](https://longbridge.com/zh-CN/quote/516500.CN.md)
- [513120.CN - 广发中证香港创新药(QDII-ETF)](https://longbridge.com/zh-CN/quote/513120.CN.md)
- [512290.CN - 国泰中证生物医药ETF](https://longbridge.com/zh-CN/quote/512290.CN.md)
- [159316.CN - 易方达恒生港股通创新药ETF](https://longbridge.com/zh-CN/quote/159316.CN.md)
- [510660.CN - 华夏医药ETF](https://longbridge.com/zh-CN/quote/510660.CN.md)
- [588130.CN - 华夏上证科创板生物医药ETF](https://longbridge.com/zh-CN/quote/588130.CN.md)
- [513700.CN - 香港医药](https://longbridge.com/zh-CN/quote/513700.CN.md)
- [516930.CN - 生物科技ETF基金](https://longbridge.com/zh-CN/quote/516930.CN.md)
- [520690.CN - 博时恒生港股通创新药精选ETF](https://longbridge.com/zh-CN/quote/520690.CN.md)
- [512010.CN - 易方达沪深300医药ETF](https://longbridge.com/zh-CN/quote/512010.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/zh-CN/news/276035104.md) |
| Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | [Link](https://longbridge.com/zh-CN/news/276056763.md) |
| AsymBio Launches Integrated Biopharma Platforms for End-to-End Development | AsymBio, a subsidiary of Asymchem Laboratories Tianjin Co. Ltd., has launched integrated technology platforms for the en | [Link](https://longbridge.com/zh-CN/news/275471539.md) |
| Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | [Link](https://longbridge.com/zh-CN/news/276024005.md) |
| Beijing Tong Ren Tang Chinese Medicine Co. Ltd. Held Extraordinary General Meeting | Beijing Tong Ren Tang Chinese Medicine Co. Ltd. held an extraordinary general meeting on February 11, 2026, where all pr | [Link](https://longbridge.com/zh-CN/news/275583242.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。